{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T21:17:24Z","timestamp":1718399844230},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.7759\/cureus.59470","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T18:17:35Z","timestamp":1714587455000},"source":"Crossref","is-referenced-by-count":1,"title":["Advancing Prostate Cancer Staging: A Single-Step Approach With Bi-parametric and Whole-Body Diffusion MRI in an African Cohort"],"prefix":"10.7759","author":[{"given":"George","family":"Asafu Adjaye Frimpong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Aboagye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Asante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwaku Addai  A","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osei","family":"Owusu-Afriyie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adwoa O","family":"Asare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorcas","family":"Atuobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard D","family":"Akpaloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bright","family":"Antwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.02.055","article-title":"A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens","volume":"62","author":"Fine SW","year":"2012","unstructured":"Fine SW, Amin MB, Berney DM, et al.. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol. 2012, 62:20-39. 10.1016\/j.eururo.2012.02.055","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-018-0458-1","article-title":"Short review of biparametric prostate MRI","volume":"11","author":"Steinkohl F","year":"2018","unstructured":"Steinkohl F, Pichler R, Junker D. Short review of biparametric prostate MRI. Memo. 2018, 11:309-12. 10.1007\/s12254-018-0458-1","journal-title":"Memo"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.08.032","article-title":"Diagnostic accuracy of a rapid biparametric MRI protocol for detection of histologically proven prostate cancer","volume":"122","author":"Obmann VC","year":"2018","unstructured":"Obmann VC, Pahwa S, Tabayayong W, et al.. Diagnostic accuracy of a rapid biparametric MRI protocol for detection of histologically proven prostate cancer. Urology. 2018, 122:133-8. 10.1016\/j.urology.2018.08.032","journal-title":"Urology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2017.58.5.994","article-title":"Comparison of multiparametric and biparametric MRI in first round cognitive targeted prostate biopsy in patients with PSA levels under 10 ng\/mL","volume":"58","author":"Lee DH","year":"2017","unstructured":"Lee DH, Nam JK, Lee SS, Han JY, Lee JW, Chung MK, Park SW. Comparison of multiparametric and biparametric MRI in first round cognitive targeted prostate biopsy in patients with PSA levels under 10 ng\/mL. Yonsei Med J. 2017, 58:994-9. 10.3349\/ymj.2017.58.5.994","journal-title":"Yonsei Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12112025","article-title":"Immediate hypersensitivity reaction to gadolinium-based MR contrast media","volume":"264","author":"Jung JW","year":"2012","unstructured":"Jung JW, Kang HR, Kim MH, Lee W, Min KU, Han MH, Cho SH. Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology. 2012, 264:414-22. 10.1148\/radiol.12112025","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11443","article-title":"Biparametric versus multiparametric MRI with non-endorectal coil at 3T in the detection and localization of prostate cancer","volume":"37","author":"Scialpi M","year":"2017","unstructured":"Scialpi M, Prosperi E, D'Andrea A, et al.. Biparametric versus multiparametric MRI with non-endorectal coil at 3T in the detection and localization of prostate cancer. Anticancer Res. 2017, 37:1263-71. 10.21873\/anticanres.11443","journal-title":"Anticancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140847","article-title":"Dynamic contrast-enhanced MR imaging curve-type analysis: is it helpful in the differentiation of prostate cancer from healthy peripheral zone?","volume":"275","author":"Hansford BG","year":"2015","unstructured":"Hansford BG, Peng Y, Jiang Y, et al.. Dynamic contrast-enhanced MR imaging curve-type analysis: is it helpful in the differentiation of prostate cancer from healthy peripheral zone?. Radiology. 2015, 275:448-57. 10.1148\/radiol.14140847","journal-title":"Radiology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2018.01.028","article-title":"Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: comparison between readers with different experience","volume":"101","author":"Di Campli E","year":"2018","unstructured":"Di Campli E, Delli Pizzi A, Seccia B, et al.. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: comparison between readers with different experience. Eur J Radiol. 2018, 101:17-23. 10.1016\/j.ejrad.2018.01.028","journal-title":"Eur J Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2252-4","article-title":"Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA","volume":"36","author":"M\u00fcller S","year":"2018","unstructured":"M\u00fcller S, Lilleaasen G, Sand TE, et al.. Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA. World J Urol. 2018, 36:687-91. 10.1007\/s00345-018-2252-4","journal-title":"World J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27485","article-title":"Whole-body magnetic resonance imaging for prostate cancer assessment: current status and future directions","volume":"55","author":"Van Nieuwenhove S","year":"2022","unstructured":"Van Nieuwenhove S, Van Damme J, Padhani AR, et al.. Whole-body magnetic resonance imaging for prostate cancer assessment: current status and future directions. J Magn Reson Imaging. 2022, 55:653-80. 10.1002\/jmri.27485","journal-title":"J Magn Reson Imaging"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2018.06.003","article-title":"Whole-body magnetic resonance imaging in oncology: uses and indications","volume":"26","author":"Petralia G","year":"2018","unstructured":"Petralia G, Padhani AR. Whole-body magnetic resonance imaging in oncology: uses and indications. Magn Reson Imaging Clin N Am. 2018, 26:495-507. 10.1016\/j.mric.2018.06.003","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"ref13","article-title":"Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas","volume":"22","author":"Castillo M","year":"20011","unstructured":"Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. American journal of neuroradiology. 20011, 22:60-4.","journal-title":"American journal of neuroradiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.1105","article-title":"Relationship between bone marrow cellularity and apparent diffusion coefficient","volume":"13","author":"Nonomura Y","year":"2001","unstructured":"Nonomura Y, Yasumoto M, Yoshimura R, Haraguchi K, Ito S, Akashi T, Ohashi I. Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging. 2001, 13:757-60. 10.1002\/jmri.1105","journal-title":"J Magn Reson Imaging"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham JA","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA, et al.. Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management. J Urol. 2022, 208:10-8. 10.1097\/JU.0000000000002757","journal-title":"J Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.02.071","article-title":"Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy","volume":"198","author":"Robertson NL","year":"2017","unstructured":"Robertson NL, Sala E, Benz M, et al.. Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy. J Urol. 2017, 198:65-70. 10.1016\/j.juro.2017.02.071","journal-title":"J Urol"},{"key":"ref17","article-title":"Whole-body magnetic resonance imaging is superior to skeletal scintigraphy for the detection of bone metastatic tumors: a meta-analysis","volume":"24","author":"Sun G","year":"2020","unstructured":"Sun G, Zhang YX, Liu F, Tu N. Whole-body magnetic resonance imaging is superior to skeletal scintigraphy for the detection of bone metastatic tumors: a meta-analysis. Eur Rev Med Pharmacol Sci. 2020, 24:","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4111\/icu.2017.58.5.324","article-title":"Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer?","volume":"58","author":"Lee DH","year":"2017","unstructured":"Lee DH, Nam JK, Jung HS, Kim SJ, Chung MK, Park SW. Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer?. Investig Clin Urol. 2017, 58:324-30. 10.4111\/icu.2017.58.5.324","journal-title":"Investig Clin Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1027411","article-title":"Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial","volume":"55","author":"Jambor I","year":"2016","unstructured":"Jambor I, Kuisma A, Ramadan S, et al.. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol. 2016, 55:59-67. 10.3109\/0284186X.2015.1027411","journal-title":"Acta Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22764","article-title":"One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified \"all-in-one\" imaging approach?","volume":"74","author":"Pasoglou V","year":"2014","unstructured":"Pasoglou V, Larbi A, Collette L, et al.. One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified \"all-in-one\" imaging approach?. Prostate. 2014, 74:469-77. 10.1002\/pros.22764","journal-title":"Prostate"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7306","article-title":"Current status of MRI and PET in the NCCN guidelines for prostate cancer","volume":"17","author":"Mason BR","year":"2019","unstructured":"Mason BR, Eastham JA, Davis BJ, Mynderse LA, Pugh TJ, Lee RJ, Ippolito JE. Current status of MRI and PET in the NCCN guidelines for prostate cancer. J Natl Compr Canc Netw. 2019, 17:506-13. 10.6004\/jnccn.2019.7306","journal-title":"J Natl Compr Canc Netw"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-021-00432-4","article-title":"Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort","volume":"21","author":"Donners R","year":"2021","unstructured":"Donners R, Yiin RS, Blackledge M, Koh DM. Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort. Cancer Imaging. 2021, 21:64. 10.1186\/s40644-021-00432-4","journal-title":"Cancer Imaging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S283299","article-title":"Current opinion on the use of magnetic resonance imaging in staging prostate cancer: a narrative review","volume":"14","author":"Michael J","year":"2022","unstructured":"Michael J, Neuzil K, Altun E, Bjurlin MA. Current opinion on the use of magnetic resonance imaging in staging prostate cancer: a narrative review. Cancer Manag Res. 2022, 14:937-51. 10.2147\/CMAR.S283299","journal-title":"Cancer Manag Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181fc679e","article-title":"Prostate cancer topography and patterns of lymph node metastasis","volume":"34","author":"Tokuda Y","year":"2010","unstructured":"Tokuda Y, Carlino LJ, Gopalan A, et al.. Prostate cancer topography and patterns of lymph node metastasis. Am J Surg Pathol. 2010, 34:1862-7. 10.1097\/PAS.0b013e3181fc679e","journal-title":"Am J Surg Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-014-1903-9","article-title":"Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis","volume":"43","author":"Shen G","year":"2014","unstructured":"Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET\/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol. 2014, 43:1503-13. 10.1007\/s00256-014-1903-9","journal-title":"Skeletal Radiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23196","article-title":"Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: therapeutic perspectives on targeted management of oligometastatic disease","volume":"76","author":"Larbi A","year":"2016","unstructured":"Larbi A, Dallaudi\u00e8re B, Pasoglou V, et al.. Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: therapeutic perspectives on targeted management of oligometastatic disease. Prostate. 2016, 76:1024-33. 10.1002\/pros.23196","journal-title":"Prostate"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2018.06.001","article-title":"Extraprostatic extension (pT3a) in prostate biopsy is an under-recognized feature indicating high risk disease","volume":"35","author":"Tolonen TT","year":"2018","unstructured":"Tolonen TT, Riikonen J, Tammela TL, Koivusalo L, Haapasalo H, Kujala P, Kaipia A. Extraprostatic extension (pT3a) in prostate biopsy is an under-recognized feature indicating high risk disease. Ann Diagn Pathol. 2018, 35:80-4. 10.1016\/j.anndiagpath.2018.06.001","journal-title":"Ann Diagn Pathol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(98)90457-9","article-title":"Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer","volume":"29","author":"Wheeler TM","year":"1998","unstructured":"Wheeler TM, Dillioglugil O, Kattan MW, et al.. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol. 1998, 29:856-62. 10.1016\/s0046-8177(98)90457-9","journal-title":"Hum Pathol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000371","article-title":"Re: A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI","volume":"202","author":"Siegel C","year":"2019","unstructured":"Siegel C. Re: A grading system for the assessment of risk of extraprostatic extension of prostate cancer at multiparametric MRI. J Urol. 2019, 202:440-1. 10.1097\/JU.0000000000000371","journal-title":"J Urol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-023-01428-3","article-title":"Radiologic-pathologic correlation of prostatic cancer extracapsular extension (ECE)","volume":"14","author":"Guerra A","year":"2023","unstructured":"Guerra A, Flor-de-Lima B, Freire G, Lopes A, Cassis J. Radiologic-pathologic correlation of prostatic cancer extracapsular extension (ECE). Insights Imaging. 2023, 14:88. 10.1186\/s13244-023-01428-3","journal-title":"Insights Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238455-advancing-prostate-cancer-staging-a-single-step-approach-with-bi-parametric-and-whole-body-diffusion-mri-in-an-african-cohort","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T18:17:38Z","timestamp":1714587458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238455-advancing-prostate-cancer-staging-a-single-step-approach-with-bi-parametric-and-whole-body-diffusion-mri-in-an-african-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.59470","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}